BIO-Europe® 2016: Peter Fong on Genentech's science shopping list, recent BioNtech deal

November 24, 2016
"Peter Fong, associate director of oncology business development at Genentech Inc. (a division of Roche), speaks to Mike Ward, global director of content for Informa Pharma Intelligence, about his role within the company and the type of deals Genentech is looking for in the cancer space. Fong explains more about Genentech's oncology focuses, seeking the best science and how a typical biotech deal works for the company. He also talks about the behind-the-scenes setup for Genentech's recent multi-million-dollar deal with messenger RNA drug developer, BioNTech AG."
Previous Video
BIO-Europe® 2016: Dimerix CEO explains company's different drug combo R&D strategy
BIO-Europe® 2016: Dimerix CEO explains company's different drug combo R&D strategy

Global director of content for Informa Pharma Intelligence, Mike Ward, talks to Kathy Harrison, CEO of Aust...

Next Video
Digital Medicine – The Intersection of  Technology and Medicine
Digital Medicine – The Intersection of Technology and Medicine

The connectivity that will be created by the convergence of computers and health will truly alter the way k...